tiprankstipranks
Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
US Market
NYMXF
Nymox Pharmaceutical
RESEARCH TOOLSreports

Nymox Pharmaceutical (NYMXF) Income Statement

142 Followers

Nymox Pharmaceutical Income Statement

Last quarter (Q4 2024), Nymox Pharmaceutical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Nymox Pharmaceutical's net income was $-857.00K. See Nymox Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Mar 23Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00-
Gross Profit
$ -1.00K$ -11.00K$ -12.00K$ -12.00K-
Operating Expenses
$ 4.28M$ 8.34M$ 6.64M$ 12.49M$ 11.71M
Depreciation and Amortization
$ 1.00K$ 11.00K$ 12.00K$ 12.00K-
EBITDA
$ -4.26M$ -8.77M$ -6.52M$ -12.49M$ -11.71M
Operating Income
$ -4.28M$ -8.35M$ -6.65M$ -12.50M$ -11.72M
Other Income/Expenses
$ -209.00K$ -494.00K$ 76.00K$ -33.00K$ -18.00K
Pretax Income
$ -4.49M$ -8.84M$ -6.58M$ -12.54M$ -11.74M
Net Income
$ -4.49M$ -8.84M$ -6.58M$ -12.54M$ -11.74M
Per Share Metrics
Basic EPS
$ -0.05$ -0.10$ -0.07$ -0.15$ -0.16
Diluted EPS
$ -0.05$ -0.10$ -0.07$ -0.15$ -0.16
Weighted Average Shares Outstanding
 93.67M 91.69M 89.38M 81.98M 73.82M
Weighted Average Shares Outstanding (Diluted)
 93.67M 91.69M 89.38M 81.98M 73.82M
Currency in USD

Nymox Pharmaceutical Earnings and Revenue History